Articles > Popular publications > PR Newswire press releases > April-June 1995 > Friday, June 2

Article: GLAXO INC. RECEIVES CLEARANCE TO MARKET IMITREX(R) TABLETS IN U.S.

Article from:
PR Newswire
Article date:
June 2, 1995
Copyright

RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire/ -- Glaxo Wellcome Inc. has received clearance from the United States Food and Drug Administration to market the tablet form of Imitrex(R) (sumatriptan succinate). Imitrex is the company's breakthrough therapy for the acute treatment of migraine and is currently available in the United States in subcutaneous (beneath the skin) injection form only.

The introduction of Imitrex Tablets will mark the availability of the first and only highly selective 5-HT(1) receptor-agonist migraine therapy in a tablet form. In worldwide markets, tablets account for more than 80 percent of sumatriptan sales.

Imitrex Tablets will ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: New Research Shows Imitrex(R) (Sumatriptan Succinate) ...
PR Newswire;  June 27, 2005 ;     700+ words ... ... PRNewswire/ -- New data show that Imitrex Tablets formulated with RT Technology ... more quickly than conventional Imitrex Tablets. The findings of this study ... five migraine sufferers compared Imitrex Tablets formulated with RT Technology ...

Article: Imitrex Tablets demonstrate rapid onset of pain ...
Drug Week;  October 22, 2004 ;     700+ words ... ... New data demonstrating that Imitrex Tablets, formulated with RT Technology ... 6% of patients treated with Imitrex 100-mg tablets reported onset ... and 19% of those treated with Imitrex 50-mg tablets reported onset ...

Article: Teva Gets FDA Approval for Generic Imitrex Tablets.
Health & Beauty Close-Up;  February 13, 2009 ;     572 words ... ... for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of GlaxoSmithKline's Imitrex Tablets, 25 mg, 50 mg and 100 mg for treatment of acute migraine attacks. Shipment of the product has commenced. According ...

Article: Imitrex available in a new formulation.
Health & Medicine Week;  March 1, 2004 ;     700+ words ... ... announced the availability of new Imitrex tablets, a new formulation of GSK ... safety profile of the conventional Imitrex tablets, now with technology for rapid ... rapid-release technology of new Imitrex tablets works differently from oral disintegrating ...

Article: Imitrex Injection And Tablets Proven Effective In ...
PR Newswire;  June 30, 1998 ;     700+ words ... ... Injection (6mg) and the other with Imitrex Tablets (100mg). The study for Imitrex ... experienced such sensitivities. Imitrex Tablets were also effective in treating ... twice the number of women taking Imitrex Tablets experienced relief from migraine ...

Article: Imitrex(R) (Sumatriptan Succinate) Tablets Now Available ...
PR Newswire;  February 4, 2004 ;     700+ words ... ... safety profile of the conventional Imitrex tablets now with an innovative technology ... rapid-release technology of new Imitrex tablets works differently from oral disintegrating ... dissolve on the tongue. New Imitrex tablets, which replace the old tablets ...

Article: IMITREX(R) TABLETS NOW AVAILABLE FOR PEOPLE WITH MIGRAINE ...
PR Newswire;  September 6, 1995 ;     700+ words ... ... Wellcome Inc. The introduction of Imitrex Tablets will mark availability of the ... minimize patient suffering. "Imitrex Tablets will enable a spectrum of migraine ... In clinical studies with Imitrex Tablets, up to 45 percent of patients ...

Article: Study Shows Imitrex(R) (sumatriptan succinate) Tablets ...
PR Newswire;  October 2, 2003 ;     700+ words ... ... having a mild pain phase preceding a moderate/severe pain phase. Patients were randomized to receive Imitrex Tablets 50 mg, Imitrex Tablets 100 mg, or placebo and were instructed to take the medication within one hour of the onset of mild pain ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives